Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / TRYP - Tryp Therapeutics discusses unique approach to psychedelic treatment study of binge eating

TRYP - Tryp Therapeutics discusses unique approach to psychedelic treatment study of binge eating

SonicShares Airlines, Hotels, Cruise Lines ETF

(NewsDirect)

Tryp Therapeutics CEO James Gilligan joinsNatalie Stoberman from the Proactive studio to share how the companyis developing psychedelic-assisted therapy in treating variousdisorders such as binge eating and IBS.

Gilligan says TrypTherapeutics is taking a unique approach with their product, TRP-8803,which is an IV infusion of psilocin, an active metabolite ofpsilocybin. Currently, Gilligan says the company is using oralpsilocybin in their studies while preparing for the use of TRP-8803.Tryp Therapeutics recently secured a $2.4 million private placementthat Gilligan says will allow the company to continue their researchand upcoming clinical trials.

ContactDetails

Proactive Investors

+1 604-688-8158

na-editorial@proactiveinvestors.com

Copyright (c) 2023 TheNewswire - All rights reserved.

Stock Information
Company Name: SonicShares Airlines, Hotels, Cruise Lines ETF
Stock Symbol: TRYP
Market: NYSE
Menu
TRYP TRYP Quote TRYP Short TRYP News TRYP Articles TRYP Message Board
Get TRYP Alerts

News, Short Squeeze, Breakout and More Instantly...